Excedrin

NDC 67751-119 · Navajo Manufacturing Company Inc.

Generic nameAcetaminophen, Aspirin (NSAID), and Caffeine

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)ACETAMINOPHEN, ASPIRIN, CAFFEINE

Strength250; 250; 65 mg/1; mg/1; mg/1

Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]

Marketing categoryOTC MONOGRAPH DRUG

Packages

67751-119-01 — 1 POUCH in 1 CARTON (67751-119-01) / 2 TABLET, FILM COATED in 1 POUCH

67751-119-02 — 2 POUCH in 1 CARTON (67751-119-02) / 2 TABLET, FILM COATED in 1 POUCH

67751-119-06 — 3 POUCH in 1 CARTON (67751-119-06) / 2 TABLET, FILM COATED in 1 POUCH

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

67296-2204 — Butalbital, Acetaminophen and Caffeine, 67296-2239 — acetaminophen and codeine phosphate, 67414-239 — Acetaminophen, Aspirin (NSAID) and Caffeine, 67414-402 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, 67414-449 — ACETAMINOPHEN, 67414-507 — ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, 67414-608 — ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, 67457-940 — Acetaminophen, 67544-002 — acetaminophen and codeine phosphate, 67544-003 — acetaminophen and codeine phosphate, 67751-129 — Aspirin, 67751-145 — ACETAMINOPHEN, CAFFEINE, and PYRILAMINE MALEATE, 67751-167 — ACETAMINOPHEN, 67751-211 — Ibuprofen, Acetaminophen, 67751-215 — Acetaminophen, Aspirin, Caffeine, 67751-217 — chlorpheniramine maleate, acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, 67751-219 — Alka-Seltzer Original Flavor, 67751-226 — caffeine, 67751-239 — Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride, 67751-240 — Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride, +4118 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels